Duhao Net

Duhao Net helps individual entrepreneurs and enterprises find high-quality suppliers, reduce procurement costs, and make transactions easier.

Hebei Meihe Pharmaceutical Co., Ltd.: A veterinary anthelmintic API supplier

Release time：2025-06-27 22:21:22 Source：DuHao

Contact Us Today

Tel : +86 0514-82778972

Email: net.fei@163.com

Address: No. 8, Xingyuan Road, Bio-Industry Park, Nanbaishe Town, Zhao County, Shijiazhuang, Hebei, China.

Hebei Meihe Pharmaceutical Co., Ltd. is a leading innovative high-tech enterprise specializing in the research, development, and production of veterinary anthelmintic active pharmaceutical ingredients (APIs). Established in 2011 and headquartered in Zhao County, Shijiazhuang City, Hebei Province, the company has grown into a key player in the veterinary pharmaceutical industry, recognized for its technological innovation, product quality, and sustainable development.

Company Overview

With a registered capital of 21 million yuan, Meihe Pharmaceutical operates from the Bio-Industrial Park in Nanbaishe Town, focusing on high-quality veterinary APIs. Its core products include:

  • Ivermectin (annual output: 100 tons)

  • Acetamido-avermectin (annual output: 10 tons)

  • Albendazole (annual output: 500 tons)

The company has achieved remarkable growth, with compound annual growth rates of:

  • Operating income: 25.33%

  • Net profit: 45.58%

  • Tax contributions: 24.66%

  • R&D investment: 39.26%

Enterprise Qualifications & Honors

Meihe Pharmaceutical holds multiple prestigious certifications and awards, including:

  • National High-Tech Enterprise

  • Hebei Province "Specialized, Refined, and Innovative" (SRDI) SME

  • Provincial Science & Technology-Based SME

  • ISO 9001 (Quality), ISO 14001 (Environmental), and ISO 45001 (Occupational Health & Safety) certifications

  • Third Prize of Hebei Science & Technology Progress Award

  • Second Prize of Shijiazhuang Science & Technology Progress Award

  • AAA-Level Quality & Contract-Compliant Enterprise

R&D & Innovation

The company boasts strong R&D capabilities, supported by:

  • Provincial Enterprise Technology Center

  • Class B R&D Institution

  • Strategic partnerships with the Lanzhou Animal Husbandry & Veterinary Drug Research Institute (CAAS) and Hebei University of Science & Technology

  • 36 authorized patents and 3 trademarks

  • 5 API production approvals

Future Vision

Under the leadership of General Manager Meng Lie, Meihe Pharmaceutical is committed to:

  • Sustaining high-intensity R&D investment to advance veterinary anthelmintic technology.

  • Expanding upstream and downstream industrial chains to enhance market competitiveness.

  • Building a national veterinary anthelmintic API production base to support the high-quality development of the industry.

"We are honored to be recognized as a 'City Gazelle Enterprise' and will continue striving for excellence to benefit global breeders," said Meng Lie. With a strong foundation in innovation and policy support, Hebei Meihe Pharmaceutical is poised to become a global leader in veterinary APIs.

DuHao Net